AQST — AQUESTIVE THERAPEUTICS

Ownership history in PARK CIRCLE Co  ·  4 quarters on record

This page tracks every 13F SEC filing in which PARK CIRCLE Co reported a position in AQUESTIVE THERAPEUTICS (AQST). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.01%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 2,500 +1,000 +66.7% 0.01% $14K $5.59
2025 Q2 UNCHANGED 1,500 — 0% 0.00% $5K $3.31
2025 Q1 UNCHANGED 1,500 — 0% 0.00% $4K $2.90
2024 Q4 INITIATED 1,500 — — 0.00% $5K $3.56
% of Fund (quarterly)    AQST price (monthly, adj. close)

Other funds also holding AQST

As of 2025 Q4 — sorted by position size

Bratton Capital Management, L.P. 3Y 7Y 100.0% Samsara BioCapital, LLC 3Y 7Y 1.67% Everstar Asset Management, LLC 1.19% Latash Investments, LLC 3Y 7Y 1.05% Sio Capital Management, LLC 3Y 7Y 1.01% EcoR1 Capital, LLC 3Y 7Y 0.77% DAFNA Capital Management LLC 3Y 7Y 0.56% RTW INVESTMENTS, LP 3Y 7Y 0.4% Blue Owl Capital Holdings LP 3Y 0.25% Ikarian Capital, LLC 3Y 0.25%
← Back to PARK CIRCLE Co Holdings